Association between cardiac biomarkers and LVEF after congenital heart disease surgery in infants

Yuxiao Mo1, Qing Feng1, Xia Wang1

  • 1Department of Pediatrics, Women and Children's Hospital, Zhongnan Hospital, Wuhan University, Wuhan, China.

Frontiers in Pediatrics
|November 28, 2025
PubMed

Insights

Cardiac biomarkers like high-sensitivity troponin I (hs-TnI) and creatine kinase-MB (CK-MB) help assess myocardial injury after congenital heart disease (CHD) surgery in young children. Their peak levels predict cardiac function and complications.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Surgery
  • Biomarker Research

Background:

  • Cardiac biomarkers are crucial for evaluating postoperative myocardial injury.
  • Limited pediatric studies exist on the relationship between cardiac biomarkers and function post-surgery.
  • Congenital heart disease (CHD) surgery in infants requires careful monitoring of cardiac status.

Purpose of the Study:

  • To characterize dynamic changes in cardiac biomarkers after CHD surgery in pediatric patients (0-3 years).
  • To assess the correlation between these biomarkers and cardiac function (LVEF).
  • To evaluate the predictive accuracy of biomarkers for cardiac dysfunction, complications, and mortality.

Main Methods:

  • Retrospective enrollment of 63 pediatric patients (0-3 years) undergoing CHD surgery.
  • Measurement of cardiac biomarkers and left ventricular ejection fraction (LVEF) preoperatively and within 1 week postoperatively.
  • Analysis of associations between biomarkers and LVEF, using ROC curves for predictive accuracy.

Main Results:

  • Biomarker levels peaked on postoperative day 1, declining within a week.
  • LVEF showed initial decrease, recovering by postoperative days 4-7.
  • Peak hs-TnI and CK-MB levels correlated negatively with LVEF on postoperative day 1.
  • hs-TnI and CK-MB demonstrated good predictive power for cardiac dysfunction and complications, but limited value for early mortality.

Conclusions:

  • Hs-TnI and CK-MB are key biomarkers reflecting myocardial injury and cardiac function recovery post-CHD surgery in pediatric patients.
  • Peak postoperative levels of hs-TnI and CK-MB can predict cardiac function recovery and composite complications.
  • These findings aid in monitoring and managing pediatric patients after CHD surgery.
Abstract